Loading…
West Pharmaceutical Services, Inc. is projected to rise to $426.86 by 2027, a +26% move from its current price of $339.59. WST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $333.76 | $339.81 | $345.96 | +0.06% |
| Aug 2 | $331.51 | $340.03 | $348.77 | +0.13% |
| Aug 3 | $329.83 | $340.25 | $350.99 | +0.19% |
| Aug 4 | $328.46 | $340.46 | $352.91 | +0.26% |
| Aug 5 | $327.28 | $340.68 | $354.63 | +0.32% |
| Aug 6 | $326.24 | $340.90 | $356.22 | +0.39% |
| Aug 7 | $325.30 | $341.12 | $357.71 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $325.30 | $341.12 | $357.71 | +0.45% |
| Week 2 | $320.40 | $342.66 | $366.46 | +0.90% |
| Week 3 | $317.03 | $344.20 | $373.71 | +1.36% |
| Week 4 | $314.43 | $345.75 | $380.20 | +1.82% |
| Week 5 | $312.33 | $347.31 | $386.21 | +2.27% |
| Week 6 | $310.57 | $348.88 | $391.91 | +2.73% |
| Week 7 | $309.08 | $350.45 | $397.36 | +3.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and regulatory expertise, and after-sales technical support.
The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. West Pharmaceutical Services, Inc.
was founded in 1923 and is headquartered in Exton, Pennsylvania.
The stock is currently priced at $328.20. It has a market capitalization of $23.1B and is ranked 491. The forecast shows upside across the horizon, with the 2026 average price at $328.20 rising to $728.05 by 2030, $2,009.57 by 2040, and $4,509.98 by 2050.
The predicted ROIs are 0% in 2026, 121.8% by 2030, 512.3% by 2040, and 1,274.2% by 2050, with a bullish overall trend.
A major floor 28.9% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 7.7% above — a clean break opens room to run.
A major ceiling 13.4% above — clearing it would confirm fresh momentum.
Key WST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $334.70 | Buy | $339.46 | Buy |
| MA 10 | $345.72 | Sell | $343.55 | Sell |
| MA 20 | $352.02 | Sell | $346.07 | Sell |
| MA 50 | $337.44 | Buy | $335.44 | Buy |
| MA 100 | $304.64 | Buy | $315.28 | Buy |
| MA 200 | $284.50 | Buy | $294.39 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.84 | Neutral |
| Stoch RSI (14) | 30.88 | Neutral |
| CCI (20) | -95.70 | Neutral |
| Williams %R (14) | -66.73 | Info |
| MACD (12,26,9) | -3.75 | Sell |
| ROC (12) | -5.05 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 33.27 | Neutral |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | -12.21 | Sell |
| Ultimate (7,14,28) | 34.62 | Neutral |
| Momentum (10) | -22.85 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 331.50 | Buy |
| ADX (14) | 24.00 | Sell |
| ATR (14) | 4.85 | Info |
The near-term picture is bullish. The RSI14 is 40, suggesting momentum could pick up if price action strengthens. The stock trades with the SMA50 at $334.74 and above the SMA200 at $283.07, indicating a positive trend relative to both moving averages.
The 30-day range spans from $287.93 to $374.11, defining key support and resistance levels near $323.59 and $365.74 respectively.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $230.95 | $339.59 | $441.70 | 0% | Neutral | |
| $350.00 | $426.86 | $544.01 | +26% | Bullish | |
| $405.90 | $504.47 | $660.58 | +49% | Bullish | |
| $542.74 | $685.03 | $916.33 | +102% | Bullish | |
| $624.60 | $799.07 | $1,088.27 | +135% | Bullish | |
| $676.73 | $876.39 | $1,212.55 | +158% | Bullish | |
| $778.46 | $1,019.56 | $1,430.82 | +200% | Bullish | |
| $831.21 | $1,100.15 | $1,564.00 | +224% | Bullish | |
| $921.39 | $1,231.67 | $1,771.97 | +263% | Bullish | |
| $1,119.38 | $1,510.54 | $2,197.46 | +345% | Bullish | |
| $1,666.78 | $2,346.11 | $3,577.11 | +591% | Bullish | |
| $3,557.30 | $5,370.52 | $8,778.50 | +14.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $230.95 | $339.59 | $395.45 | +0.00% |
| August 2026 | $297.79 | $347.23 | $412.62 | +2.25% |
| September 2026 | $307.05 | $360.08 | $431.91 | +3.70% |
| October 2026 | $306.83 | $361.47 | $436.80 | +0.39% |
| November 2026 | $301.36 | $356.37 | $433.23 | -1.41% |
| December 2026 | $304.54 | $361.36 | $441.70 | +1.40% |
Click any year to see its month-by-month WST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
West Pharmaceutical Services, Inc.'s 2026 outlook centres on $339.59, within a $230.95 to $441.70 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, WST could reach as high as $544.01, with a base case around $426.86 and support toward $350.00 — roughly +26% from $339.59. Momentum favours further upside here.
Expect WST to range from $405.90 to $660.58 through 2028. The $504.47 average target implies a +49% move from current prices. That is up +18% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The WST price prediction for 2029 points to an average of $685.03 (low $542.74, high $916.33) — a potential gain of +102% on today's $339.59. Momentum favours further upside here.
In 2030, WST is projected to trade between $624.60 and $1,088.27, averaging $799.07 — a potential gain of +135% from today's $339.59. That is up +17% on the projected 2029 average. Buyers look set to stay in control over this stretch.
West Pharmaceutical Services, Inc.'s 2031 outlook centres on $876.39, within a $676.73 to $1,212.55 range. That is up +10% on the projected 2030 average. That marks a +158% change versus current levels. Momentum favours further upside here.
By 2032, WST could reach as high as $1,430.82, with a base case around $1,019.56 and support toward $778.46 — roughly +200% from $339.59. Buyers look set to stay in control over this stretch.
Expect WST to range from $831.21 to $1,564.00 through 2033. The $1,100.15 average target implies a +224% move from current prices. That is up +8% on the projected 2032 average. Momentum favours further upside here.
The WST price prediction for 2034 points to an average of $1,231.67 (low $921.39, high $1,771.97) — a potential gain of +263% on today's $339.59. Buyers look set to stay in control over this stretch.
In 2035, WST is projected to trade between $1,119.38 and $2,197.46, averaging $1,510.54 — a potential gain of +345% from today's $339.59. That is up +23% on the projected 2034 average. Momentum favours further upside here.
West Pharmaceutical Services, Inc.'s 2040 outlook centres on $2,346.11, within a $1,666.78 to $3,577.11 range. That is up +55% on the projected 2035 average. That marks a +591% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, WST could reach as high as $8,778.50, with a base case around $5,370.52 and support toward $3,557.30 — roughly +14.8x from $339.59. Momentum favours further upside here.
Investing $1,000 in WST today (≈ 2.944727 WST) could be worth
$15,814.72
+$14,814.72 (+1481%) by 2050 · US Dollar
Based on the average projected WST price of $5,370.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WSTwould be worth at today's price.
$1,000 invested in WST on Jul 30, 2025 (≈ 4.01268 WST) would be worth
$1,362.67
+$362.67 (+36.3%) today · 1.36× · US Dollar
Based on a WST entry price of $249.21 vs. today's $339.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $355.48 | $955.3 | -4.5% |
| 1 month ago | $359 | $945.93 | -5.4% |
| 3 months ago | $300.68 | $1,129.41 | +12.9% |
| 6 months ago | $231.12 | $1,469.32 | +46.9% |
| 1 year ago | $249.21 | $1,362.67 | +36.3% |
| All time (5.0y) ago | $415.23 | $817.84 | -18.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WST forecast.
Our base-case forecast reaches $680.00 around 2029.
Implied market cap at $680.00: $47.86B
The multi-year forecast shows strong upside, with the 2030 average price at $728.05 and ROI of 121.8%, supported by bullish sentiment. By 2040 the average price is projected at $2,009.57 with ROI of 512.3%, and by 2050 the average price is $4,509.98 with ROI of 1,274.2%.
Tap a question to reveal the answer.
Avg price in 2030 is $728.05, with a min of $565.49 and a max of $999.77. The forecast shows an ROI of 121.8% and a bullish sentiment.
Yes, the forecast shows bullish sentiment from 2027 onward, with 2027 avg $404.20 (ROI 23.2%), 2028 avg $470.56 (ROI 43.4%), 2029 avg $633.59 (ROI 93%), and 2030 avg $728.05 (ROI 121.8%).
Yes. The max in 2030 is $999.77, and in 2031 the max rises to $1,106.17, with 2032 max $1,304.88 and 2033 $1,401.00, so it could exceed $1,000 in the early 2030s.
Current price is $328.20; market cap is $23.1B.
Sentiment is BULLISH. RSI14 is 40. The 30-day range is $287.93 to $374.11, with support at $323.59 and resistance at $365.74. The SMA50 is $334.74 and the SMA200 is $283.07.
West Pharmaceutical Services, Inc. Community Discussion
0Share your West Pharmaceutical Services, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.